Igc Pharma Inc
(IGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,196 | 4,945 | 6,623 | 8,053 | 10,460 |
| Marketable Securities | 154 | 88 | 193 | N/A | N/A |
| Receivables | 107 | 251 | 189 | 147 | 125 |
| Inventories | 2,651 | 3,748 | 3,750 | 3,622 | 3,548 |
| Other current assets | 358 | 322 | 444 | 905 | 978 |
| TOTAL | $6,466 | $9,354 | $11,199 | $12,727 | $15,111 |
| Non-Current Assets | |||||
| PPE Net | 8,213 | 8,309 | 8,470 | 9,161 | 9,419 |
| Intangibles | 1,170 | 1,022 | 952 | 937 | 917 |
| Other Non-Current Assets | 1,329 | 1,385 | 1,337 | 1,341 | 1,387 |
| TOTAL | $10,712 | $10,716 | $10,759 | $11,439 | $11,723 |
| Total Assets | $17,178 | $20,070 | $21,958 | $24,166 | $26,834 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 3 | N/A |
| Accounts payable and accrued liabilities | 530 | 466 | 456 | 456 | 981 |
| Accrued Expenses | 1,368 | 890 | 926 | 1,200 | 1,460 |
| TOTAL | $1,898 | $1,356 | $1,382 | $1,659 | $2,441 |
| Non-Current Liabilities | |||||
| Long Term Debt | 141 | 141 | 142 | 143 | 144 |
| Other Non-Current Liabilities | 228 | 256 | 290 | 324 | 357 |
| TOTAL | $369 | $397 | $432 | $467 | $501 |
| Total Liabilities | $2,267 | $1,753 | $1,814 | $2,126 | $2,942 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 53,077 | 53,077 | 53,067 | 52,534 | 51,744 |
| Common Shares | 118,965 | 118,382 | 117,899 | 117,171 | 116,019 |
| Retained earnings | -100,665 | -96,635 | -94,386 | -91,944 | -89,159 |
| Other shareholders' equity | -3,389 | -3,430 | -3,369 | -3,187 | -2,968 |
| TOTAL | $14,911 | $18,317 | $20,144 | $22,040 | $23,892 |
| Total Liabilities And Equity | $17,178 | $20,070 | $21,958 | $24,166 | $26,834 |